Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Title
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PSYCHIATRY
Volume 165, Issue 8, Pages 1033-1039
Publisher
American Psychiatric Publishing
Online
2008-07-02
DOI
10.1176/appi.ajp.2008.06091591

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started